SCHEMBL3669666

SCHEMBL3669666

Clc1ccc2c(I)c(Cl)ccc2n1.Clc1ccc2nc(Cl)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.37
HTR3A P46098 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
TYMS P04818 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
C1R P00736 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
POLB P06746 1/20 0.33
CYP2A6 P11509 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
FABP3 P05413 1/20 0.32
FABP4 P15090 1/20 0.32
FABP5 Q01469 1/20 0.32
TP53 P04637 1/20 0.31
TEC P42680 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011498 0.87 CRHBP (0.39) CRHBPCRHR2
SCHEMBL29447040 0.81 BACE1 (0.50) BACE1HTR3AHRH4HRH3CYP2A6
SCHEMBL198060 0.81 BACE1 (0.50) BACE1HTR3AHRH4HRH3CYP2A6
SCHEMBL3666214 0.73 BACE1 (0.43) BACE1HTR3AHRH4TYMSHRH3
SCHEMBL1598979 0.70 BACE1 (0.39) BACE1TYMS
SCHEMBL22791436 0.70 HTR3A (0.45) BACE1HTR3AHRH4TYMSHRH3
SCHEMBL22951353 0.69 IDO1 (0.38) BACE1
SCHEMBL2133059 0.67 NR4A2 (0.54) BACE1HTR3AHRH3MAPTMAPK1
SCHEMBL30506415 0.67 NR4A2 (0.54) BACE1HTR3AHRH3MAPTMAPK1
SCHEMBL2130719 0.66 BACE1 (0.72) BACE1TEC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139879-A1 QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES AstraZeneca AB (SE) 2010-01-06 EP disclosed
WO-2008114002-A1 QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2008-09-25 WO disclosed